Rpi 856 A
| Code | Size | Price |
|---|
| TAR-T24737-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Rpi 856 A is a retrovirus protease inhibitor. It is effective against HIV-1 and HTLV-1 proteases.
CAS:
157381-54-9
Formula:
C43H61N7O13
Molecular Weight:
883.997
Purity:
0.98
SMILES:
CC(C)C[C@H](NC(=O)C(NC(=O)[C@@H](N)C(C)C)c1cc(O)cc(O)c1)C(=O)N([C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O)C(=O)C(=O)C(N)Cc1ccccc1
References
1. Kitazaki T, Asano T, Kato K, Kishimoto S, Itoh K. Synthesis and human immunodeficiency virus (HIV)-1 protease inhibitory activity of tripeptide analogues containing a dioxoethylene moiety. Chem Pharm Bull (Tokyo). 1994 Dec;42(12):2636-40. PubMed PMID: 7697778.
2. Asano T, Matsuoka K, Hida T, Kobayashi M, Kitamura Y, Hayakawa T, Iinuma S, Kakinuma A, Kato K. Novel retrovirus protease inhibitors, RPI-856 A, B, C and D, produced by Streptomyces sp. AL-322. J Antibiot (Tokyo). 1994 May;47(5):557-65. PubMed PMID: 8040053.